Given the pathogenesis of asthma, MSTN could be also a useful biomarker of asthma in horses; however, the skeletal muscle mass and/or training status could also be factors influencing plasma MSTN concentration in horses [9,19]. This evidence concerns the gene MSTN and asthma.